Research reveals transport mechanisms of Coenzyme A into mitochondria in cellular function — Evidence Review
Published in Nature Metabolism, by researchers from Yale University
Researched by
— the AI search engine for science
Table of Contents
A new study reveals how coenzyme A (CoA), derived from vitamin B5, is imported into mitochondria through specific transporters—a long-standing question in cell biology. Related research broadly supports these findings, highlighting the central role of CoA in metabolism and disease.
- Prior reviews and mechanistic studies confirm that mitochondrial carriers are essential for transporting vitamin B–derived cofactors, including CoA, into mitochondria, and that defects in these transporters can disrupt cell metabolism and cause disease 1 7 8.
- Research on metabolic diseases links impaired CoA transport or low vitamin B5 status to neurodegenerative and metabolic disorders, supporting the new study's focus on disease relevance 1 7 8 9.
- The critical functions of CoA and its derivatives in energy production, cellular signaling, and metabolic regulation have been extensively reviewed, aligning with the study's findings on the importance of precise CoA compartmentalization and transport 2 3 6.
Study Overview and Key Findings
Understanding how cells supply mitochondria with essential cofactors is vital because disruptions in these metabolic processes can have widespread effects on organ function and health. This study addresses a fundamental knowledge gap: how the majority of cellular coenzyme A (CoA), a molecule central to energy metabolism and derived from vitamin B5, reaches the mitochondria where it is most needed. The research overcomes longstanding technical barriers by employing advanced mass spectrometry to analyze CoA forms and uses genetic approaches to identify the transporters responsible for mitochondrial import.
| Property | Value |
|---|---|
| Organization | Yale University |
| Journal Name | Nature Metabolism |
| Authors | Hongying Shen, PhD |
| Population | Cells, specifically mitochondria |
| Outcome | Transport mechanisms of Coenzyme A into mitochondria |
| Results | CoA is imported into mitochondria via specific transporters. |
Literature Review: Related Studies
To place these findings in context, we searched the Consensus database, which includes over 200 million research papers. The following search queries were used to identify relevant literature:
- vitamin B5 mitochondrial transport mechanisms
- CoA transporters cellular energy production
- vitamin B5 deficiency cellular effects
| Topic | Key Findings |
|---|---|
| How do mitochondria import CoA and other vitamin B–derived cofactors? | - Mitochondrial inner membranes are highly selective, requiring dedicated carrier proteins for the import of CoA and similar cofactors 1. - Mutations in transporter genes disrupt mitochondrial metabolism and are linked to a range of diseases 1 7 9. |
| What are the metabolic and cellular consequences of altered CoA or vitamin B5 levels? | - CoA and its derivatives are essential for energy metabolism, protein acetylation, and cellular signaling 2 3 6. - Deficiencies in vitamin B5 or CoA metabolism are associated with neurodegenerative diseases and metabolic disorders, such as Alzheimer's and Huntington's disease 7 8. |
| Can vitamin B5 supplementation or manipulation of CoA levels influence health and disease? | - Vitamin B5 supplementation can improve defects in models of metabolic and genetic disorders involving CoA metabolism 9. - Transient vitamin B5 deprivation may improve cell fitness and protein production in certain contexts, suggesting complex roles for B5 in cellular homeostasis 10. |
How do mitochondria import CoA and other vitamin B–derived cofactors?
Related studies consistently demonstrate the necessity of specialized transporters for importing CoA and other B-vitamin–derived cofactors into mitochondria. The impermeability of the mitochondrial inner membrane makes these transporters crucial for normal metabolism. The new study provides direct experimental evidence for the existence and function of such transporters, confirming and extending the mechanistic framework established by earlier reviews and genetic studies 1.
- Mitochondrial carrier proteins are required for the import of CoA, thiamine pyrophosphate, FAD, and NAD+ 1.
- Disease-causing mutations in cofactor transporter genes can impair mitochondrial enzyme activity and metabolic pathways 1 7.
- The present study's identification of specific CoA transporters supports predictions from previous literature 1.
- Mechanistic insights from genetic and biochemical studies in model organisms further corroborate the need for dedicated import systems 9.
What are the metabolic and cellular consequences of altered CoA or vitamin B5 levels?
Research highlights that CoA is not only a metabolic intermediate but also acts as a signaling molecule, influencing processes such as energy production, gene regulation, and protein modification 2 3 6. Disruptions in CoA synthesis or transport, as well as vitamin B5 deficiency, are linked to diverse pathologies, including neurodegeneration and impaired cellular function. The new study's disease focus aligns with these observations, shedding light on how mitochondrial CoA deficits may contribute to disease 7 8 9.
- Acetyl-CoA and other CoA derivatives regulate metabolic enzymes, gene expression, and cellular signaling 2 3 6.
- Low vitamin B5 levels are observed in the brains of patients with Alzheimer's and Huntington's disease, potentially contributing to neurodegeneration 7 8.
- Mutations affecting CoA metabolism or transport can trigger developmental delays, epilepsy, and muscle disorders 1 7 9.
- Proper CoA compartmentalization is essential for metabolic flexibility and cellular adaptation 3 4 5.
Can vitamin B5 supplementation or manipulation of CoA levels influence health and disease?
Interventional studies and model systems suggest that modulating vitamin B5 or CoA availability can influence disease outcomes and cell health. Supplementation with B5 has shown promise in experimental models of genetic and metabolic diseases, though the effects may be context-dependent. The new study's mechanistic findings may help guide future therapeutic strategies targeting mitochondrial CoA transport 9 10 11.
- Vitamin B5 supplementation improved cellular and organismal defects in models of TANGO2 deficiency disease 9.
- Transient B5 deprivation in cultured cells increased fitness and therapeutic protein production, possibly through metabolic adaptation 10.
- The effects of B5 on immune function, wound healing, and inflammation are documented but require further mechanistic clarification 11.
- Understanding the regulation of mitochondrial CoA import may allow for targeted interventions in diseases with identified metabolic deficits 7 9.
Future Research Questions
Continued research is needed to clarify how CoA transport is regulated in different tissues, how disruptions contribute to specific diseases, and whether therapeutic modulation of vitamin B5 or CoA transport can be effective and safe. Addressing these questions will help translate mechanistic insights into clinical advances for metabolic and neurodegenerative diseases.
| Research Question | Relevance |
|---|---|
| How is mitochondrial CoA import regulated in different cell types? | Regulation may differ between neurons, muscle, and other tissues, affecting disease susceptibility and progression 1 7 8. Understanding tissue-specific mechanisms could inform targeted therapies. |
| What are the molecular consequences of mutations in CoA transporters? | Elucidating the cellular and metabolic disruptions caused by transporter mutations will clarify their roles in disease and guide genetic screening and intervention strategies 1 7 9. |
| Can vitamin B5 supplementation restore mitochondrial CoA levels and function in disease? | Evidence suggests B5 supplementation may ameliorate symptoms in certain disorders, but its effectiveness and safety across patient populations need to be rigorously tested 7 8 9. |
| Are there additional transporters or mechanisms for CoA import into mitochondria? | Unidentified import pathways may exist, and their discovery could expand therapeutic targets and deepen understanding of mitochondrial metabolism 1 5. |
| How does altered CoA compartmentalization influence metabolic flexibility and disease risk? | Disrupted compartmentalization may impair cellular adaptation to stress, promote metabolic disease, and contribute to neurodegeneration 2 3 6 7. Detailed studies could reveal new intervention points. |